Literature DB >> 20569760

Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.

John Fanikos1, Leslie Ann Stevens, Matthew Labreche, Gregory Piazza, Elaine Catapane, Lena Novack, Samuel Z Goldhaber.   

Abstract

OBJECTIVE: We compared adherence to unfractionated heparin (UFH) 2 or 3 times daily prophylaxis orders versus low-molecular-weight heparin (LMWH) once daily orders. Our goals were to determine which strategy demonstrated the best adherence in terms of timing and frequency of dose administration, and to determine reasons for ordered heparin not being administered.
METHODS: We queried our electronic medication administration record where nurses document reasons for delayed administration or omitted doses. We identified 250 consecutive patients who were prescribed prophylaxis with UFH 2 or 3 times daily or LMWH once daily. We followed patients for their hospitalization to determine adherence to physicians' prophylaxis orders.
RESULTS: Adherence, defined as the ratio of prophylaxis doses given to doses ordered, was greater with LMWH (94.9%) than UFH 3 times daily (87.8%) or UFH twice daily (86.8%) regimens (P <.001). Patients receiving LMWH more often received all of their scheduled prophylaxis doses (77%) versus UFH 3 times daily (54%) or UFH twice daily (45%) (P <.001). There were no differences between regimens regarding reasons for omitted doses. The most common reason for late or omitted doses was patient refusal, which explained 44% of the UFH and 39% of the LMWH orders that were not administered.
CONCLUSIONS: LMWH once a day had better adherence than UFH 2 or 3 times daily. For both LMWH and UFH, patient refusal was the most common reason for not administering prophylaxis as prescribed. These findings require consideration when evaluating pharmacological prophylaxis strategies. Educational programs, explaining the rationale, may motivate patients to improve adherence during hospitalization. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569760     DOI: 10.1016/j.amjmed.2009.11.017

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  What the 2018 ASH venous thromboembolism guidelines omitted: nonadministration of pharmacologic prophylaxis in hospitalized patients.

Authors:  Oluwafemi P Owodunni; Brandyn D Lau; Michael B Streiff; Peggy S Kraus; Deborah B Hobson; Dauryne L Shaffer; Kristen L W Webster; Mujan Varasteh Kia; Christine G Holzmueller; Elliott R Haut
Journal:  Blood Adv       Date:  2019-02-26

2.  The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis.

Authors:  J L Pleet; B P Vaughn; J A Morris; A C Moss; A S Cheifetz
Journal:  Aliment Pharmacol Ther       Date:  2014-03-10       Impact factor: 8.171

3.  Missed Doses of Venous Thromboembolism (VTE) Prophylaxis at Community Hospitals: Cause for Alarm.

Authors:  Brandyn D Lau; Michael B Streiff; Peggy S Kraus; Deborah B Hobson; Dauryne L Shaffer; Jonathan K Aboagye; Peter J Pronovost; Elliott R Haut
Journal:  J Gen Intern Med       Date:  2018-01       Impact factor: 5.128

4.  Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis.

Authors:  Kara L Piechowski; Stacy Elder; Leigh E Efird; Elliott R Haut; Michael B Streiff; Brandyn D Lau; Peggy S Kraus; Cynthia S Rand; Victor O Popoola; Deborah B Hobson; Norma E Farrow; Dauryne Shaffer; Kenneth M Shermock
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

5.  Measuring non-administration of ordered medications in the pediatric inpatient setting.

Authors:  Haresh L Bhatia; Neal R Patel; Catherine H Ivory; Phillip W Stewart; Kim M Unertl; Christoph U Lehmann
Journal:  Int J Med Inform       Date:  2017-11-21       Impact factor: 4.046

6.  Missed Doses of Venous Thromboembolism Prophylaxis: a Growing Problem Without an Active Management Strategy.

Authors:  Brandyn D Lau; Jiangxia Wang; Deborah B Hobson; Peggy S Kraus; Dauryne L Shaffer; Michael B Streiff; Elliott R Haut
Journal:  J Gen Intern Med       Date:  2020-11-02       Impact factor: 5.128

Review 7.  Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies.

Authors:  Kenneth M Shermock; Brandyn D Lau; Elliott R Haut; Deborah B Hobson; Valerie S Ganetsky; Peggy S Kraus; Leigh E Efird; Christoph U Lehmann; Brian L Pinto; Patricia A Ross; Michael B Streiff
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  Educating surgical patients to reduce the risk of venous thromboembolism: an audit of an effective strategy.

Authors:  Hazim Sadideen; John M O'Callaghan; Maziar Navidi; Mazin Sayegh
Journal:  JRSM Short Rep       Date:  2011-12-15

9.  Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis.

Authors:  Anthony D Yang; Daniel Brock Hewitt; Eddie Blay; Lindsey J Kreutzer; Christopher M Quinn; Kimberly A Cradock; Vivek Prachand; Karl Y Bilimoria
Journal:  Ann Surg       Date:  2020-06       Impact factor: 13.787

Review 10.  Practices to prevent venous thromboembolism: a brief review.

Authors:  Brandyn D Lau; Elliott R Haut
Journal:  BMJ Qual Saf       Date:  2013-05-24       Impact factor: 7.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.